BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
...te for genital herpes,
ImmunoVEX HSV2.
ImmunoVEX
hsv2 is a novel live-attenuated vaccine which has been
... genital
herpes. In preclinical studies, ImmunoVEX
hsv2 completely prevented all
symptoms of genital herpe...owerful immune response,
suggesting that ImmunoVEX
hsv2 may be more potent than other HSV-2 vaccines
for w...
BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
...am is a vaccine for genital herpes, ImmunoVEX
HSV2, which provides complete protection in animal models of the disease. A
Phase I study with ImmunoVEX
hsv2 is scheduled to commence in the third
quarter of 2008.
For further information, please go to http://www.biovex.com .
...
BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
...am is a vaccine for genital herpes, ImmunoVEX
HSV2, which provides complete protection in animal models of the disease. A
Phase I study with ImmunoVEX
hsv2 is scheduled to commence in the third
quarter of 2008.
For further information, please go to http://www.biovex.com .
...
BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
...am is a vaccine for genital herpes, ImmunoVEX
HSV2, which provides complete protection in animal models of the disease. A
Phase I study with ImmunoVEX
hsv2 is scheduled to initiate later this year.
For more information visit the company's website at http://www.biovex.com .
...
HSV2 in Biological Technology
BioVex to Present at the UBS Global Life Sciences Conference
...linical studies,
ImmunoVEXHSV2 completely prevented all symptoms of genital herpes and
triggered a powerful immune response, suggesting that ImmunoVEX
hsv2 may be
more potent than other HSV-2 vaccines for which data has been published.
For further information, please go to http://www.biovex.com .
...
BioVex Closes Second Round of Series E Financing
...am is a vaccine for genital herpes, ImmunoVEX
HSV2, which provides complete protection in animal models of the disease. A
Phase I study with ImmunoVEX
hsv2 is scheduled to initiate at the end of
the year. For more information visit the company's website at
http://www.biovex.com .
...
BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
...am is a vaccine for genital herpes, ImmunoVEX
HSV2, which provides complete protection in animal models of the disease. A
Phase I study with ImmunoVEX
hsv2 is scheduled to initiate later this year. For more information visit the company's website at http://www.biovex.com .
...
HSV2 in Biological Products